Please note that UPSpace will be unavailable from Friday, 2 May at 18:00 (South African Time) until Sunday, 4 May at 20:00 due to scheduled system upgrades. We apologise for any inconvenience this may cause and appreciate your understanding.
dc.contributor.author | Manyombe, Martin Luther Mann![]() |
|
dc.contributor.author | Mbang, Joseph![]() |
|
dc.contributor.author | Lubuma, Jean M.-S.![]() |
|
dc.contributor.author | Tsanou, Berge![]() |
|
dc.date.accessioned | 2016-07-21T05:41:32Z | |
dc.date.issued | 2016-08 | |
dc.description.abstract | In this paper, an epidemic model is investigated for infectious diseases that can be transmitted through both the infectious individuals and the asymptomatic carriers (i.e., infected individuals who are contagious but do not show any disease symptoms). We propose a dose-structured vaccination model with multiple transmission pathways. Based on the range of the explic- itly computed basic reproduction number, we prove the global stability of the disease-free when this threshold number is less or equal to the unity. Moreover, whenever it is greater than one, the existence of the unique endemic equilibrium is shown and its global stability is established for the case where the changes of displaying the disease symptoms are independent of the vulnerable classes. Further, the model is shown to exhibit a transcritical bifurcation with the unit basic reproduction number being the bifurcation parameter. The impacts of the asymptomatic carriers and the e ectiveness of vaccination on the disease transmission are discussed through through the local and the global sensitivity analyses of the basic reproduction number. Finally, a case study of hepatitis B virus disease (HBV) is considered, with the numerical simulations presented to support the analytical results. They further suggest that, in high HBV prevalence countries, the combination of e ective vaccination (i.e. 3 doses of HepB vaccine), the diagnosis of asymptomatic carriers and the treatment of symptomatic carriers may have a much greater positive impact on the disease control. | en_ZA |
dc.description.department | Mathematics and Applied Mathematics | en_ZA |
dc.description.embargo | 2017-08-31 | |
dc.description.librarian | hb2016 | en_ZA |
dc.description.sponsorship | South African Research Chairs Initiatives (SARChI Chair), in Mathematical Models and Methods in Bioengineering and Biosciences. | en_ZA |
dc.description.uri | http://www.elsevier.com/locate/msec | en_ZA |
dc.identifier.citation | Manyombe, MLM, Mbang, J, Lubuma, J & Tsanou, B 2016, 'Global dynamics of a vaccination model for infectious diseases with asymptomatic carriers', Mathematical Biosciences and Engineering, vol. 13, no. 4, pp. 813-840. | en_ZA |
dc.identifier.issn | 0928-4931 (print) | |
dc.identifier.other | 10.3934/mbe.2016019 | |
dc.identifier.uri | http://hdl.handle.net/2263/56000 | |
dc.language.iso | en | en_ZA |
dc.publisher | Elsevier | en_ZA |
dc.rights | © 2016 Elsevier B.V. All rights reserved. Notice : this is the author’s version of a work that was accepted for publication in Materials Science and Engineering: C. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to This article since it was submitted for publication. A definitive version was subsequently published in Materials Science and Engineering: C, vol. 13, no. 4, pp. 813-840, 2016. doi : 10.3934/mbe.2016019. | en_ZA |
dc.subject | Epidemic model | en_ZA |
dc.subject | Investigated for infectious diseases | en_ZA |
dc.subject | Infectious individuals | en_ZA |
dc.subject | Asymptomatic carriers | en_ZA |
dc.subject | Hepatitis B virus (HBV) | en_ZA |
dc.title | Global dynamics of a vaccination model for infectious diseases with asymptomatic carriers | en_ZA |
dc.type | Postprint Article | en_ZA |